Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAL: HDM-AIT on Anti-viral Immunity in Allergic Asthma
NCT04100902Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jan 2020
- Primary completion
- Feb 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of SQ SLIT-tablet in allergic asthma, sponsored by Bispebjerg and Frederiksberg Hospital. Started Jan 2020; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT04100902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04100902.